Literature DB >> 23894833

[Dynamics of IL-22-producing cells of mice infected with Schistosoma japonicum].

Yong Li1, Xiao-Wei Yang, Xiao-Xiao Dong, Xiao-Jun Chen, Zhi-Peng Xu, Wei-Wei Zhang, Xue Xue, Wen-Jun Kong, Sha Zhou, Ji-Feng Zhu, Feng Liu, Chuan Su.   

Abstract

OBJECTIVE: To study the dynamics of IL-22-producing cells and analyze the main source of IL-22 of mice infected with Schistosoma japonicum.
METHODS: The lymphocytes and splenocytes were prepared from lymphnodes and spleens of mice with S. japonicum infection at different stages (0 w, 3 w, 5w, 8 w, 13 w after infection). The proportions of IL-22-producing cells were determined by FACS.
RESULTS: The proportions of IL-22-producing cells increased significantly in the lymphocytes and splenocytes from the mice infected with S. japonicum. The IL-22-producing T cells accounted 80% of the total IL-22-producing cells. The IL-22-producing CD4- T cells increased obviously in the 3rd week after S. japonicum infection. However, the proportion of the IL-22-producing CD4+ T cells began to rise since the 3rd week post-infection, and increased significantly at the 8th week after infection.
CONCLUSION: In the lymphnodes and spleens of mice infected with S. japonicum, IL-22 is produced by both T cells and non-T cells, and T cells are the most important source of IL-22. The IL-22-producing CD4- T cells increase rapidly in the early acute inflammatory response, and the IL-22-producing CD4+ T cells increase significantly during the chronic inflammatory phase.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23894833

Source DB:  PubMed          Journal:  Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi        ISSN: 1005-6661


  1 in total

1.  Praziquantel treatment after Schistosoma japonicum infection maintains hepatic insulin sensitivity and improves glucose metabolism in mice.

Authors:  Xiaofeng Luo; Yuxiao Zhu; Ran Liu; Jingwei Song; Fan Zhang; Wenyue Zhang; Zhipeng Xu; Min Hou; Bingya Yang; Lin Chen; Minjun Ji
Journal:  Parasit Vectors       Date:  2017-10-02       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.